Global Human Growth Hormone (HGH) Market Insights, Clinical Analysis by Medical Experts

Global Human Growth Hormone (HGH) Market: Industry Analysis & Outlook (2018-2022) analyzes the development of this market along with the market opportunities. The report contains a comprehensive analysis of the global market along with the study of the regional markets

Human growth hormone is produced by the pituitary gland and it spurs growth in children and adults. It regulates body fluids, muscle and bone growth and fat metabolism of the body.

Get inside look of the Report with Sample PDF at: http://orbisresearch.com/contacts/request-sample/2097729?utm_source=sru

Growth hormone is important for normal functioning in humans. The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD) and it can be tackled by administering intramuscular or subcutaneous GH injections on daily basis.

The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have being profiled along with their key financials and strategies for growth.

In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD. The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.

The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting HGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.

Browse full Report at: http://orbisresearch.com/reports/index/global-human-growth-hormone-hgh-market-industry-analysis-and-outlook-2018-2022?utm_source=sru

Table of Content:

1.Market Overview
1.1 Human Growth Hormone
1.2 Physiological Effects of hGH
1.3 GH Deficiency (GHD)
1.4 Recombinant Human Growth Hormone (rhGH)
1.5 hGH Market by Indications

2.Global hGH Market
2.1 Global hGH Market by Value
2.2 Global hGH Market Forecast by Value
2.3 Global hGH Market by Volume
2.4 Global hGH Market Forecast by Volume
2.5 Global hGH Market Share by Indication
2.6 Global hGH Market by Indication
2.6.1 Global Pediatric GHD Market Forecast by Value (2017-2022)
2.6.2 Global Other GHD Market Forecast by Value (2017-2022)
2.7 Global hGH Market by Therapeutics
2.8 Global hGH Market Forecast by Therapeutics
2.9 Global hGH Market by Region

3.Regional Markets
3.1 The US
3.1.1 The US hGH Market Forecast by Value
3.1.2 The US hGH Market by Indication
3.1.3 The US Pediatric GHD Patient Population Forecast
3.1.4 The US Pediatric GHD Patient Population by Type
3.2 Europe
3.2.1 Europe hGH Market Forecast by Value
3.2.2 Europe hGH Market by Indication
3.2.3 Europe Pediatric GHD Patient Population Forecast
3.2.4 Europe Pediatric GHD Patient Population by Type
3.3 Japan
3.3.1 Japan hGH Market Forecast by Value
3.3.2 Japan hGH Market by Indication
3.3.3 Japan Pediatric GHD Patient Population Forecast
3.3.4 Japan Pediatric GHD Patient Population by Type

4.Global Human Growth Hormone Market Opportunity
4.1 VRS-317
4.1.1 VRS-317 – The US Growth Hormone Deficiency Market
4.1.2 VRS-317 – European Union (EU) Growth Hormone Deficiency Market
4.1.3 VRS-317 –Japan Growth Hormone Deficiency Market
4.2 TransCon hGH
4.2.1 TransCon hGH –The US and ROW Growth Hormone Deficiency Market

5.Market Dynamics
5.1 Growth Drivers
5.1.1 Long-Acting hGH Formulations in Development
5.1.2 Increasing Incidence of Cancer and HIV/AIDS
5.1.3 Rise in GDP Per Capita
5.1.4 Increased Spending on Medicines
5.1.5 Increasing Global Healthcare Expenditure
5.2 Trends & Development
5.2.1 Use of TransCon Technology
5.2.2 Development of Auto-Injectors
5.2.3 Rapid Conversion of the Existing Market to Long-Acting Agents
5.3 Challenges
5.3.1 High Cost of Treatment
5.3.2 High R&D Costs
5.3.3 Side Effects of rhGH
5.3.4 Low Share of Biosimilar

6.Competitive Landscape
6.1 Global hGH Market
6.1.1 Global hGH Market Share Volume by Company
6.1.2 Pediatric GHD-Long-Acting Hgh Formulations by Company
6.1.3 Adult GHD-Long-Acting Hgh Formulations by Company
6.2 The US hGH Market

7.Company Profiles
7.1 Novartis AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Pfizer Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Eli Lilly and Company
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Novo Nordisk A/S
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

Request to Purchase Copy of the Report at: http://orbisresearch.com/contact/purchase/2097729?utm_source=sourabh

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.